AVENE

AVENE XERACALM A.D. OIL 400ML

You're reading an Auto-translation.

XeraCalm A.D. Lipid-replenishing cleansing oil is intended for very dry skin prone to atopic eczema and itching. The product is the first step in the anti-itching ritual, leaves the skin soft, comfortable, and respects the skin's microbiome. This product gently cleanses and soothes very dry skin prone to atopic eczema and itching.

Soap-free and with a physiological pH, XeraCalm A.D. Lipid-replenishing cleansing oil can be used during flare-ups on the face, body, and scalp.
Its formula combines a postbiotic active ingredient derived from Avène Thermal Spring Water, I-modulia®, which reduces itching caused by skin dryness, stimulates the skin's defense mechanism, and fights against irritations, along with the Cer-omega ingredient, skin-like lipids known for their nourishing effect and for restoring the skin barrier, and Avène thermal water, which is soothing and anti-irritant.
Fragrance-free product developed to minimize the risk of allergic reactions, it does not irritate the eyes and is ideal for the skin of newborns, children, and adults.

AVENE THERMAL SPRING WATER (AVENE AQUA). GLYCERIN. WATER (AQUA). HYDROGENATED STARCH HYDROLYSATE. DISODIUM COCOAMPHODIACETATE. DECYL GLUCOSIDE. POLYSORBATE 20. SODIUM CHLORIDE. CETEARETH-60 MYRISTYL GLYCOL. AQUAPHILUS DOLOMIAE EXTRACT. ARGININE. CITRIC ACID. COCO-GLUCOSIDE. EVENING PRIMROSE OIL/PALM OIL AMINOPROPANEDIOL ESTERS. GLYCERYL OLEATE. GLYCINE. HYDROGENATED VEGETABLE GLYCERIDES CITRATE. SIMMONDSIA CHINENSIS (JOJOBA) SEED OIL (SIMMONDSIA CHINENSIS SEED OIL). SODIUM BENZOATE. TOCOPHEROL. TRISODIUM ETHYLENEDIAMINE DISUCCINATE

I-modulia®- Patented postbiotic active ingredient from Avène thermal spring water. Reduces itching, stimulates skin defense, and fights against irritations.

Cer-omega- Skin-like lipids. Nourishes and restores the skin barrier.

Avène Thermal Spring Water- Strengthens the skin barrier and alleviates skin discomfort.

Disclaimers:

1. Tolerability and efficacy study, 55 subjects (adults, children, infants) under dermatological and pediatric control.
2. Evaluation of the moisturizing effect over 24 hours compared to an untreated area and after a single application on 22 subjects.
3. Tolerability and efficacy study, 55 subjects (adults, children, infants) under dermatological and pediatric control. 1-2 applications per day for 3 weeks, evaluation of pruritus after 3 weeks.